Ozempic knockoffs flood US market thanks to ‘blind spot’ in FDA rules | US healthcare

  Medicine

US healthcare

Obscure statute grants reproduction of drugs in shortages – creating $1bn market of unbranded weight-loss drugs

Mon 22 Jul 2024 14.07 EDT

An obscure federal statute is allowing US pharmacies to flood the market with unvetted knockoffs of Ozempic, the pricey weight-loss drug that is…



Source link